NSF International will be exhibiting at the leading UK pharmaceutical exhibition and conference, Making Pharmaceuticals, at the Ricoh Arena in Coventry, UK. The exhibition features companies that are fundamental to every stage of the lifecycle of a pharmaceutical product, and the conference covers the major topics and issues facing the pharmaceutical industry.

On 30 April – 1 May, join us for a coffee and a chat with our team at stand 216. You will learn all about our EDGE toolkit and pharma biotech services -- including world-class regulatory and compliance consulting, auditing and training -- and you can also get involved in our open discussion on what questions are key in your organization, if you want to create long-term sustainable growth.

On 30 April, Lynne Byers, NSF International’s Executive Director of Pharma Biotech will present the session Managing Active Pharmaceutical Ingredient Supply Chains at 14:50 p.m. in room B. Lynne will use the recent Valsartan recalls to examine how API supply chains should be managed. The presentation will use ICH Q9 principles to examine how companies and regulators use the standard. Lynne will also show how the regulatory framework supports regulators and marketing authorisation holders to assure API supply chains.

Pete Gough, Executive Director of Pharma Biotech, who has 45 years’ experience in the industry and for the past 15 years has been responsible for advising senior management regarding changes to pharmaceutical legislation and guidance, will present The Impact of Brexit on Pharmaceuticals session on 1 May at 14:20 p.m. in room B. Pete’s presentation will focus on the current and, as far as can be seen, the future impact of Brexit on the supply of medicinal products in both the EU and UK.

Register early at www.makingpharma.com to avoid the queues when you arrive. If you arrive before 10 a.m., you can enjoy breakfast on us! NSF look forward to seeing you. If you would like to schedule a meeting with our team, please get in touch.